Stay updated on ADP-A2M4CD8 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the ADP-A2M4CD8 in Ovarian Cancer Clinical Trial page.

Latest updates to the ADP-A2M4CD8 in Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedThe footer/footer build label for the site updates to a new revision version (v3.5.3), with no visible change to the ClinicalTrials.gov record history content.SummaryDifference0.1%

- Check11 days agoChange DetectedNew history entry Revision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.5.0 was added and revision: v3.4.3 was deleted from the Record History.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the history.SummaryDifference0.1%

- Check61 days agoChange DetectedSponsor/collaborator details changed from Adaptimmune to USWM CT, LLC and USWM, LLC (dba US WorldMeds). New sections Oversight, Sponsor/Collaborators, Study Status, and Study Identification were added, with updates dated February 2026.SummaryDifference1%

- Check76 days agoChange DetectedA new revision entry (v3.4.2) was added and an older revision/notice (v3.4.1) was removed. These are administrative changes and do not alter core study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to ADP-A2M4CD8 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADP-A2M4CD8 in Ovarian Cancer Clinical Trial page.